(Q43048336)

12 November 2017

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

1 reference

5

1 reference

12 November 2017

8

1 reference

12 November 2017

12

1 reference

12 November 2017

Jonathan K Ball

11

0 references

Dennis R. Burton

14

object named as

Dennis R Burton

1 reference

12 November 2017

Mansun Law

1

1 reference

12 November 2017

Toshiaki Maruyama

2

1 reference

12 November 2017

Jamie Lewis

3

1 reference

12 November 2017

Erick Giang

4

1 reference

12 November 2017

Zania Stamataki

6

1 reference

12 November 2017

Pablo Gastaminza

7

1 reference

12 November 2017

Ian M Jones

9

1 reference

12 November 2017

Robert I Fox

10

1 reference

12 November 2017

Norman M Kneteman

13

1 reference

12 November 2017

language of work or name

English

0 references

publication date

6 December 2007

1 reference

12 November 2017

3

1 reference

based on heuristic

inferred from page(s)

published in

Nature Medicine

1 reference

12 November 2017

14

1 reference

12 November 2017

25-27

1 reference

12 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1698

12 November 2017

0 references

cites work

Binding of hepatitis C virus to CD81

1 reference

CD81-Dependent Binding of Hepatitis C Virus E1E2 Heterodimers

21 January 2018

1 reference

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

21 January 2018

1 reference

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

21 January 2018

1 reference

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

21 January 2018

1 reference

A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells

21 January 2018

1 reference

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

21 January 2018

1 reference

Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application

21 January 2018

1 reference

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

21 January 2018

1 reference

Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions

21 January 2018

1 reference

Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees

21 January 2018

1 reference

A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees

21 January 2018

1 reference

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

21 January 2018

1 reference

Characterization of truncated forms of hepatitis C virus glycoproteins.

21 January 2018

1 reference

Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1038/NM1698

1 reference

12 November 2017

1 reference